Press Releases
Vernay to Showcase Advanced Fluid Control Solutions for MedTech at COMPAMED 2025 in Düsseldorf
November 5, 2025
November 5, 2025
At this year’s event, Vernay will focus on solutions that enhance precision and reliability in minimally invasive and interventional medicine. In addition, the company will demonstrate how decades of material science expertise continue to drive innovation in MedTech.
The company will highlight:
With decades of R&D and material science experience, Vernay continues to develop custom elastomeric components that meet the highest standards of performance and safety. Moreover, the company’s close partnerships with leading OEMs ensure every solution aligns with evolving MedTech requirements.
COMPAMED 2025 offers an opportunity for collaboration and knowledge sharing. Vernay looks forward to meeting partners, innovators, and engineers to discuss how its fluid control technologies can enable the next generation of medical devices.
Attendees are encouraged to visit Booth G11, Hall 8A, to connect with Vernay’s experts and explore how the company is shaping the future of MedTech innovation.
Vernay Laboratories has been a technology leader in the design, development, and manufacture of customized flow-control components since its founding in 1946. The company also formulates its own compounds to address each specific application.
Vernay’s products play a vital role in millions of medical devices, automobiles, and consumer products. Today, the privately held firm produces more than 1 billion components per year, drawing from a library of more than 33,000 elastomeric materials and compound formulations. It operates six plants around the world, in the U.S., the Netherlands, Italy and China. For more information, visit www.vernay.com.